Abstract
The frequency of chronic renal insufficiency among cancer patients is unclear. The aim of this study was to determine the frequency of impaired renal function within a population of cancer patients. One thousand two hundred seventeen patients (563 women, 654 men) with cancer underwent serum creatinine concentration and glomerular filtration rate (GFR) evaluations. The Cockcroft-Gault formula was used to estimate the GFR from the creatinine clearance (Clcr). Renal insufficiency was defined as a GFR ≤90 mL/min. Among this population, 72 (5.9%)demonstrated an abnormal serum creatinine concentration (> 1.2 mg/dL). According to the Cockcroft-Gault formula evaluations, however, 330 (27.1%) of the patients had an estimated GFR < 90 mL/min. Among these, the Clcr was between 60 and 89 mL/min in 241 patients (19.8%); 30 and 59 mL/min in 75 patients (6.2%); and 15 and 29 mL/min in 7 patients (0.6%); 7 patients (6%) had a Clcr < 15 mL/min. As a result, 21.2% of patients demonstrating a normal serum creatinine level had abnormal renal function. Renal function should be evaluated in all cancer patients, regardless of their serum creatinine level, before any drug regimen is administered. The Cockcroft-Gault formula appears to be more accurate than serum creatinine concentration for diagnosing renal insufficiency in patients with cancer, but more prospective studies in this population will be necessary to confirm this finding.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Burstein DM, Korbet SM, Schwartz MM. Membranous glomerulonephritis and malignancy. Am J Kidney Dis. 1993;22:5–10.
Alpers CE, Cotran RS. Neoplasia and glomerular injury. Kidney Int. 1986;30:465–473.
Poch E, Almirall J, Torras A, et al. Rapidly progressive glomerulonephritis and systemic vasculitis in non-Hodgkin lymphoma. Nephrol Dial Transplant. 1991;6:51–54.
Marx GM, Blake GM, Galani E, et al. Evaluation of the Cockroft-Gault, Jelliffe and Wright formulae in estimating renal function in elderly cancer patients mass. Ann Oncol. 2004;15:291–295.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16:31–41.
Launay-Vacher V, Izzedine H, Rey JB, et al. Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired patients. Med Sci Monit. 2004;10:CR209-CR212.
Beck L. Aging changes in renal function. In: Hazzard W, Blass J, Ettinger W, Halter J, Ouslander J, eds. Principles of Geriatric Medicine and Gerontology. 4th ed. New York, NY: McGraw-Hill;1999: 767–776.
Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003;21:153–158.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis. 2002;39(2 suppl 1): S1-S266.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth DA. More accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470.
Monfardini S. Evaluation of renal function in elderly cancer patients. Ann Oncol. 2004;15: 183–184.
Clase C, Garg A, Kiberd B. Prevalence of low glomerular filtration in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2002;13:1338–1349.
Verhave JC, Balje-Volkers CP, Hillege HL, de Zeeuw D, de Jong PE. The reliability of different formulae to predict creatinine clearance. J Intern Med. 2003;253:563–573.
Poole SG, Dooley MJ, Rischin D.A. Comparison of bedside renal function estimates and measured glomerular filtration rate (Tc99mDTPA clearance) in cancer patients. Ann Oncol. 2002;13:949–955.
Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res. 2002; 105:53–57.
Chang GC, Yang TY, Shih CM, Lin LY, Lee HS, Chiang CD. Serial-measured versus estimated creatinine clearance patients with non-small cell lung cancer receiving cisplatin-based chemotherapy. J Formos Med Assoc. 2003;102:257–261.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dogan, E., Izmirli, M., Ceylan, K. et al. Incidence of renal insufficiency in cancer patients. Adv Therapy 22, 357–362 (2005). https://doi.org/10.1007/BF02850082
Issue Date:
DOI: https://doi.org/10.1007/BF02850082